Cargando…

Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases

Aberrant deployment of the immune response is a hallmark pathogenic feature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-19), possibly accounting for high morbidity and mortality, especially in patients with comorbidities, including immune-mediated disorders...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramirez, Giuseppe A., Asperti, Chiara, Cucca, Valentina, Yacoub, Mona-Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537812/ https://www.ncbi.nlm.nih.gov/pubmed/34696255 http://dx.doi.org/10.3390/vaccines9101147

Ejemplares similares

Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
por: Pignatti, Patrizia, et al.
Publicado: (2023)

Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees
por: Asperti, Chiara, et al.
Publicado: (2022)

Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study
por: Cucca, Valentina, et al.
Publicado: (2022)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Current vaccine strategies against SARS-CoV-2: Promises and challenges
por: Kurup, Drishya, et al.
Publicado: (2022)

Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination
por: Madsen, Johannes Roth, et al.
Publicado: (2023)

Challenges and developments in universal vaccine design against SARS-CoV-2 variants
por: Zhao, Fangxin, et al.
Publicado: (2022)

Immunity After Vaccination Against SARS-CoV-2 in Lung Transplant?
por: López, Gema María Siesto, et al.
Publicado: (2022)

Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
por: Sieiro Santos, Cristiana, et al.
Publicado: (2022)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
por: Sunagar, Raju, et al.
Publicado: (2023)

SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assembly
por: Onnis, Anna, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
por: Mannucci, Pier Mannuccio
Publicado: (2021)

Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
por: Milne, Gregory, et al.
Publicado: (2021)

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Worsening of immune thrombocytopenic purpura in SARS-CoV-2 vaccinated patients()
por: García Ramírez, Patricia, et al.
Publicado: (2022)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination
por: Cilona, Maria Bernadette, et al.
Publicado: (2023)

Immune correlates of protection by vaccine against SARS‐CoV‐2 in patients with chronic lymphocytic leukaemia
por: Sorcini, Daniele, et al.
Publicado: (2022)

A two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge
por: Jiang, Wenwen, et al.
Publicado: (2021)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

Challenges and Issues of Anti-SARS-CoV-2 Vaccines
por: Blumental, Sophie, et al.
Publicado: (2021)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
por: Mahboob, Tooba, et al.
Publicado: (2023)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
por: Guebre-Xabier, Mimi, et al.
Publicado: (2020)

Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
por: Yu, Jingyou, et al.
Publicado: (2023)

Immune Response to SARS-CoV-2 Vaccines
por: Bellamkonda, Navya, et al.
Publicado: (2022)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
por: Kar, Sanchita, et al.
Publicado: (2022)

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
por: Syahniar, Rike, et al.
Publicado: (2022)

A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
por: Zhang, Mengxin, et al.
Publicado: (2022)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss
por: Chai, Kit Man, et al.
Publicado: (2021)

Neutralizing immunity against SARS-CoV-2 Omicron BA.1 by infection and vaccination
por: Duan, Li-Jun, et al.
Publicado: (2022)

Percentages of Vaccination Coverage Required to Establish Herd Immunity against SARS-CoV-2
por: Plans-Rubió, Pedro
Publicado: (2022)

Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
por: Tang, Jinyi, et al.
Publicado: (2022)

Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
por: Monzon-Posadas, Werner O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gel88jebh2dtrol4cbusiru8fr